Sotradecol (Mylan Institutional LLC)


Welcome to the PulseAid listing for the Sotradecol drug offered from Mylan Institutional LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Institutional LLC
NON-PROPRIETARY NAME: tetradecyl hydrogen sulfate (ester)
SUBSTANCE NAME: TETRADECYL HYDROGEN SULFATE (ESTER)
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2013-04-29
END MARKETING DATE: 0000-00-00


Sotradecol HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSotradecol from Mylan Institutional LLC
LABELER NAME: Mylan Institutional LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/mL)
START MARKETING DATE: 2013-04-29
END MARKETING DATE: 0000-00-00
PRODUCT ID: 67457-162_299c3a3f-da6e-439d-872f-15f761c152d8
PRODUCT NDC: 67457-162
APPLICATION NUMBER: ANDA040541

Other TETRADECYL HYDROGEN SULFATE (ESTER) Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Mylan Institutional LLCSotradecol